🇺🇸 FDA
Pipeline program

Personalized mRNA Tumor Vaccine

STZD-1801

Unknown mab active

Quick answer

Personalized mRNA Tumor Vaccine for Esophageal Cancer is a Unknown program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Esophageal Cancer
Phase
Unknown
Modality
mab
Status
active

Clinical trials